Qsymia® (phentermine and topiramate) extended-release tablets
Approval Date: Jun 2024
Indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management
Zepbound™ (tirzepatide) injection
Approval Date: Nov 2023
Indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in obese adults, or overweight adults with at least one weight-related comorbidity
WEGOVY™ (SEMAGLUTIDE) INJECTION
Approval Date: Jun 2021
For chronic weight management with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol) for use in addition to a reduced calorie diet and increased physical activity